Cow's milk protein allergy: Elimination-based diagnosis and the risk of overdiagnosis in infants

Cow's milk protein allergy (CMPA) is a genuine cause of morbidity in infancy, yet many complaints attributed to it are also common during normal feeding and gastrointestinal maturation. This narrative and critical review examines how diagnostic elimination is interpreted, why the confirmatory reintroduction step is often omitted, and how these practices contribute to overdiagnosis. PubMed/MEDLINE and the official publications of international allergy and pediatric gastroenterology societies were consulted in 2026, emphasizing challenge-based population studies, observational cohorts, controlled interventions, and guidance published through 2025. Challenge-confirmed allergy is substantially less frequent than parent-reported milk reactions or prescriptions for specialized formula. Symptom improvement during milk avoidance, without reproducible recurrence after reintroduction, provides weak causal evidence because symptoms fluctuate and concurrent interventions are common. The distinction between immediate IgE-mediated reactions, delayed gastrointestinal phenotypes, and ordinary infant behavior determines both the value and safety of diagnostic testing. Short, planned elimination followed by an appropriately supervised or home-based challenge, according to risk, offers a more defensible pathway than an open-ended restrictive diet. Diagnostic precision also protects breastfeeding, nutritional adequacy, family resources, and timely recognition of alternative disease. Clinicians should treat CMPA as a testable hypothesis, not as an explanation automatically assigned to nonspecific infant symptoms.

Authors

Institutions

Publication Details

Journal
International Health Sciences Review
Published
2026-11-13
DOI
https://doi.org/10.70164/ihsr.v2i6.272
Primary Topic
Food Allergy and Anaphylaxis Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Cow's milk protein allergy: Elimination-based diagnosis and the risk of overdiagnosis in infants

Miguel Augusto Passoni Amianti, Luana Alberton Medeiros, Vitor dos Santos Barbosa, Beatriz Munhoz Suhai et al.
1 links
International Health Sciences Review
Food Allergy and Anaphylaxis Research
article

Cow's milk protein allergy: Elimination-based diagnosis and the risk of overdiagnosis in infants

Miguel Augusto Passoni Amianti, Luana Alberton Medeiros, Vitor dos Santos Barbosa, Beatriz Munhoz Suhai, Milena Rizzo, Maria Eduarda Rocha de Oliveira, Arthur Schmidt Strelow, Carolina Baptista Bastos
article en

Abstract

Cow's milk protein allergy (CMPA) is a genuine cause of morbidity in infancy, yet many complaints attributed to it are also common during normal feeding and gastrointestinal maturation. This narrative and critical review examines how diagnostic elimination is interpreted, why the confirmatory reintroduction step is often omitted, and how these practices contribute to overdiagnosis. PubMed/MEDLINE and the official publications of international allergy and pediatric gastroenterology societies were consulted in 2026, emphasizing challenge-based population studies, observational cohorts, controlled interventions, and guidance published through 2025. Challenge-confirmed allergy is substantially less frequent than parent-reported milk reactions or prescriptions for specialized formula. Symptom improvement during milk avoidance, without reproducible recurrence after reintroduction, provides weak causal evidence because symptoms fluctuate and concurrent interventions are common. The distinction between immediate IgE-mediated reactions, delayed gastrointestinal phenotypes, and ordinary infant behavior determines both the value and safety of diagnostic testing. Short, planned elimination followed by an appropriately supervised or home-based challenge, according to risk, offers a more defensible pathway than an open-ended restrictive diet. Diagnostic precision also protects breastfeeding, nutritional adequacy, family resources, and timely recognition of alternative disease. Clinicians should treat CMPA as a testable hypothesis, not as an explanation automatically assigned to nonspecific infant symptoms.

International Health Sciences ReviewVol. 2(6)
Universidade Feevale (BR), Universidade de Santo Amaro (BR), Universidade do Vale do Rio dos Sinos (BR), Universidade do Extremo Sul Catarinense (BR)
Good health and well-being
Food Allergy and Anaphylaxis Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon